| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.82 | 0.002 | 0.82 | Porphobilinogen synthase inhibitor | |||
| 0.426 | 0.065 | 0.426 | Calcium channel L-type activator | |||
| 0.338 | 0.005 | 0.338 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.2 0.016 CID_129847590 | ||
| 0.348 | 0.037 | 0.399 | Superoxide dismutase inhibitor | 0.399 0.027 CID_129847590 | CID_129847590 | |
| 0.314 | 0.004 | 0.314 | Triose-phosphate isomerase inhibitor | |||
| 0.308 | 0.023 | 0.308 | DNA methyltransferase I inhibitor | 0.273 0.037 CID_129847590 | ||
| 0.277 | 0.007 | 0.519 | Histidine decarboxylase inhibitor | 0.519 0.003 CID_129847590 | CID_129847590 | |
| 0.332 | 0.063 | 0.332 | Calcium channel activator | |||
| 0.299 | 0.034 | 0.299 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.294 | 0.029 | 0.294 | DNA methylase inhibitor | 0.291 0.031 CID_129847590 | ||
| 0.277 | 0.015 | 0.277 | Succinate dehydrogenase inhibitor | |||
| 0.264 | 0.011 | 0.264 | Ferrochelatase inhibitor | |||
| 0.27 | 0.021 | 0.27 | Nitric-oxide synthase stimulant | |||
| 0.311 | 0.066 | 0.364 | Interleukin 2 agonist | 0.364 0.039 CID_129847590 | CID_129847590 | |
| 0.256 | 0.013 | 0.256 | UDP-glucose 4-epimerase inhibitor | |||
| 0.368 | 0.132 | 0.368 | Caspase 9 stimulant | |||
| 0.242 | 0.01 | 0.242 | Adenylate kinase inhibitor | 0.163 0.022 CID_129847590 | ||
| 0.238 | 0.025 | 0.238 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.227 | 0.016 | 0.227 | GABA C receptor agonist | |||
| 0.215 | 0.005 | 0.215 | DOPA decarboxylase inhibitor | |||
| 0.204 | 0.005 | 0.204 | Biliverdin reductase inhibitor | |||
| 0.227 | 0.03 | 0.347 | Phospholipase A2 inhibitor | 0.347 0.008 CID_129847590 | CID_129847590 | |
| 0.306 | 0.111 | 0.306 | Immunosuppressant | |||
| 0.207 | 0.02 | 0.76 | Aminopeptidase B inhibitor | 0.76 0.002 CID_129847590 | CID_129847590 | |
| 0.192 | 0.013 | 0.192 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.181 | 0.008 | 0.181 | Alcohol oxidase inhibitor | |||
| 0.178 | 0.014 | 0.178 | Phosphofructokinase-1 inhibitor | |||
| 0.182 | 0.028 | 0.182 | Cathepsin H inhibitor | 0.137 0.057 CID_129847590 | ||
| 0.163 | 0.011 | 0.78 | Glutamate decarboxylase inhibitor | 0.78 0.002 CID_129847590 | CID_129847590 | |
| 0.188 | 0.037 | 0.188 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.154 | 0.007 | 0.154 | GABA aminotransferase inhibitor | |||
| 0.203 | 0.073 | 0.203 | Anesthetic general | |||
| 0.15 | 0.031 | 0.15 | TRPA1 agonist | |||
| 0.175 | 0.056 | 0.215 | Neurotensin receptor agonist | 0.215 0.028 CID_129847590 | CID_129847590 | |
| 0.251 | 0.133 | 0.251 | Vasodilator, coronary | |||
| 0.205 | 0.092 | 0.294 | Peptidyltransferase inhibitor | 0.294 0.027 CID_129847590 | CID_129847590 | |
| 0.126 | 0.014 | 0.126 | Argininosuccinate synthase inhibitor | |||
| 0.127 | 0.021 | 0.166 | Glutamate dehydrogenase inhibitor | 0.166 0.013 CID_129847590 | CID_129847590 | |
| 0.164 | 0.058 | 0.164 | Amylase inhibitor | |||
| 0.113 | 0.01 | 0.113 | GABA B receptor agonist | |||
| 0.134 | 0.032 | 0.134 | Creatine kinase inhibitor | |||
| 0.142 | 0.041 | 0.142 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.116 | 0.018 | 0.116 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.107 | 0.013 | 0.107 | NMDA receptor glycine site agonist | |||
| 0.151 | 0.06 | 0.151 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.115 | 0.025 | 0.723 | Glutathione S-transferase inhibitor | 0.723 0.001 CID_129847590 | CID_129847590 | |
| 0.107 | 0.017 | 0.154 | NMDA receptor agonist | 0.154 0.008 CID_129847590 | CID_129847590 | |
| 0.101 | 0.014 | 0.101 | Androgen agonist | |||
| 0.107 | 0.022 | 0.107 | D-Ala-D-Ala ligase inhibitor | |||
| 0.088 | 0.004 | 0.088 | Glutamate (mGluR8) agonist | 0.055 0.009 CID_129847590 | ||
| 0.09 | 0.007 | 0.09 | Glutamate (mGluR4) antagonist | 0.058 0.015 CID_129847590 | ||
| 0.118 | 0.036 | 0.118 | Alcohol dehydrogenase inhibitor | 0.105 0.048 CID_129847590 | ||
| 0.086 | 0.005 | 0.086 | Kainate receptor 2 antagonist | 0.035 0.026 CID_129847590 | ||
| 0.177 | 0.097 | 0.177 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.093 | 0.013 | 0.093 | Exportin-1 inhibitor | |||
| 0.074 | 0.003 | 0.074 | Human T-cell leukemia virus type I protease inhibitor | 0.019 0.016 CID_129847590 | ||
| 0.089 | 0.019 | 0.165 | Ornithine carbamoyltransferase inhibitor | 0.165 0.009 CID_129847590 | CID_129847590 | |
| 0.206 | 0.139 | 0.206 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.088 | 0.021 | 0.088 | Purinergic P2X1 antagonist | |||
| 0.152 | 0.086 | 0.152 | Arachidonic acid antagonist | |||
| 0.115 | 0.048 | 0.115 | Carbonic anhydrase III inhibitor | |||
| 0.077 | 0.01 | 0.109 | Kainate receptor antagonist | 0.109 0.006 CID_129847590 | CID_129847590 | |
| 0.07 | 0.004 | 0.07 | Kainate receptor agonist | |||
| 0.128 | 0.063 | 0.128 | Aldehyde dehydrogenase inhibitor | |||
| 0.085 | 0.022 | 0.085 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.191 | 0.129 | 0.229 | Interleukin agonist | 0.229 0.095 CID_129847590 | CID_129847590 | |
| 0.089 | 0.027 | 0.089 | Elastase 1 inhibitor | |||
| 0.094 | 0.035 | 0.094 | Thioredoxin reductase inhibitor | |||
| 0.12 | 0.061 | 0.12 | Interleukin 8 antagonist | |||
| 0.071 | 0.013 | 0.071 | Lysophosphatidic acid 3 receptor antagonist | 0.058 0.025 CID_129847590 | ||
| 0.066 | 0.01 | 0.066 | Glutamate (mGluR group III) antagonist | |||
| 0.072 | 0.017 | 0.072 | Aconitate hydratase inhibitor | |||
| 0.11 | 0.055 | 0.11 | Urease inhibitor | |||
| 0.071 | 0.016 | 0.071 | DNA helicase inhibitor | |||
| 0.063 | 0.01 | 0.063 | Fumarate hydratase inhibitor | |||
| 0.06 | 0.01 | 0.121 | AMPA 4 receptor antagonist | 0.121 0.004 CID_129847590 | CID_129847590 | |
| 0.137 | 0.087 | 0.137 | Ca2+-transporting ATPase inhibitor | |||
| 0.086 | 0.037 | 0.198 | Aminopeptidase I inhibitor | 0.198 0.007 CID_129847590 | CID_129847590 | |
| 0.077 | 0.027 | 0.077 | NMDA 2C receptor antagonist | 0.069 0.034 CID_129847590 | ||
| 0.099 | 0.05 | 0.102 | Thioredoxin inhibitor | 0.102 0.046 CID_129847590 | CID_129847590 | |
| 0.075 | 0.027 | 0.075 | MDM2 inhibitor | |||
| 0.064 | 0.019 | 0.078 | CD45 antagonist | 0.078 0.013 CID_129847590 | CID_129847590 | |
| 0.116 | 0.072 | 0.146 | Alkylator | 0.146 0.049 CID_129847590 | CID_129847590 | |
| 0.059 | 0.015 | 0.059 | AICAR transformylase inhibitor | 0.053 0.019 CID_129847590 | ||
| 0.051 | 0.007 | 0.051 | NMDA 2D receptor antagonist | |||
| 0.062 | 0.019 | 0.062 | NMDA receptor subunit 3B antagonist | |||
| 0.204 | 0.161 | 0.204 | Cholesterol antagonist | |||
| 0.113 | 0.07 | 0.113 | Microtubule formation inhibitor | |||
| 0.149 | 0.108 | 0.561 | Phospholipase C inhibitor | 0.561 0.005 CID_129847590 | CID_129847590 | |
| 0.063 | 0.023 | 0.063 | Alpha-mannosidase inhibitor | |||
| 0.212 | 0.172 | 0.405 | Sodium/bile acid cotransporter inhibitor | 0.405 0.015 CID_129847590 | CID_129847590 | |
| 0.103 | 0.065 | 0.103 | Toll-Like receptor 4 antagonist | 0.1 0.07 CID_129847590 | ||
| 0.091 | 0.054 | 0.091 | Calcium antagonist | |||
| 0.256 | 0.22 | 0.256 | 5 Hydroxytryptamine release inhibitor | |||
| 0.062 | 0.026 | 0.062 | Dihydroorotate oxidase inhibitor | |||
| 0.075 | 0.041 | 0.075 | Phenylalanine 4-hydroxylase inhibitor | 0.072 0.044 CID_129847590 | ||
| 0.09 | 0.056 | 0.09 | NADH dehydrogenase inhibitor | |||
| 0.101 | 0.067 | 0.155 | Factor V inhibitor | 0.155 0.016 CID_129847590 | CID_129847590 | |
| 0.054 | 0.021 | 0.054 | Mannosidase inhibitor | |||
| 0.038 | 0.008 | 0.038 | Kainate receptor 1 antagonist | 0.018 0.017 CID_129847590 | ||
| 0.107 | 0.076 | 0.107 | Photosensitizer | |||
| 0.045 | 0.015 | 0.045 | Integrin alpha2 antagonist | |||
| 0.053 | 0.023 | 0.079 | Thymidylate synthase inhibitor | 0.079 0.008 CID_129847590 | CID_129847590 | |
| 0.143 | 0.114 | 0.143 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.053 | 0.025 | 0.053 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.08 | 0.051 | 0.08 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.065 | 0.038 | 0.065 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.04 | 0.014 | 0.04 | Catechol O-methyltransferase inhibitor | |||
| 0.04 | 0.014 | 0.06 | AMPA 3 receptor antagonist | 0.06 0.006 CID_129847590 | CID_129847590 | |
| 0.041 | 0.015 | 0.041 | Carnitine palmitoyltransferase inhibitor | |||
| 0.047 | 0.021 | 0.047 | NMDA receptor subunit 3A antagonist | |||
| 0.061 | 0.036 | 0.061 | Ryanodine receptor antagonist | |||
| 0.04 | 0.015 | 0.04 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.036 | 0.012 | 0.036 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.038 | 0.016 | 0.119 | AMPA 1 receptor antagonist | 0.119 0.005 CID_129847590 | CID_129847590 | |
| 0.045 | 0.023 | 0.045 | Heme oxygenase inhibitor | |||
| 0.067 | 0.046 | 0.067 | Glutamate (mGluR6) antagonist | |||
| 0.025 | 0.004 | 0.025 | Thromboxane A2 agonist | |||
| 0.032 | 0.013 | 0.032 | Kainate receptor 4 antagonist | 0.022 0.02 CID_129847590 | ||
| 0.072 | 0.053 | 0.199 | Catalase inhibitor | 0.199 0.015 CID_129847590 | CID_129847590 | |
| 0.044 | 0.024 | 0.044 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.098 | 0.079 | 0.098 | Cystathionine beta-synthase inhibitor | |||
| 0.13 | 0.111 | 0.13 | Interferon gamma antagonist | |||
| 0.052 | 0.034 | 0.052 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.053 | 0.035 | 0.092 | NMDA 2A receptor antagonist | 0.092 0.015 CID_129847590 | CID_129847590 | |
| 0.104 | 0.087 | 0.104 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.09 | 0.073 | 0.09 | Bile acid receptor antagonist | |||
| 0.036 | 0.02 | 0.036 | Free fatty acid receptor 1 antagonist | |||
| 0.02 | 0.004 | 0.02 | Glutamate (mGluR6) agonist | |||
| 0.036 | 0.02 | 0.036 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.091 | 0.077 | 0.091 | Anabolic | |||
| 0.048 | 0.034 | 0.048 | Plasminogen activator inhibitor antagonist | |||
| 0.065 | 0.052 | 0.065 | Carbonic anhydrase VA inhibitor | |||
| 0.027 | 0.014 | 0.027 | NMDA receptor glycine site antagonist | |||
| 0.027 | 0.016 | 0.027 | Integrin alpha2beta1 antagonist | |||
| 0.047 | 0.036 | 0.047 | Dopamine beta hydroxylase inhibitor | |||
| 0.116 | 0.106 | 0.116 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.019 | 0.01 | 0.019 | Kainate receptor 3 antagonist | 0.017 0.012 CID_129847590 | ||
| 0.173 | 0.164 | 0.173 | DNA synthesis inhibitor | |||
| 0.041 | 0.032 | 0.041 | Angiotensin AT1 receptor antagonist | |||
| 0.082 | 0.073 | 0.082 | Potassium channel (Ca-activated) activator | |||
| 0.018 | 0.009 | 0.018 | Thyroid hormone alpha antagonist | |||
| 0.038 | 0.029 | 0.038 | Dihydropteroate synthase inhibitor | |||
| 0.047 | 0.039 | 0.047 | Thromboxane A2 antagonist | |||
| 0.022 | 0.014 | 0.022 | Kainate receptor 5 antagonist | |||
| 0.114 | 0.106 | 0.453 | Peroxidase inhibitor | 0.453 0.014 CID_129847590 | CID_129847590 | |
| 0.02 | 0.013 | 0.02 | Progesterone receptor B antagonist | |||
| 0.011 | 0.007 | 0.011 | Thromboxane agonist | |||
| 0.014 | 0.01 | 0.014 | Angiotensin AT1B receptor antagonist | |||
| 0.048 | 0.044 | 0.048 | Thromboxane antagonist | |||
| 0.046 | 0.042 | 0.079 | Collagenase inhibitor | 0.079 0.008 CID_129847590 | CID_129847590 | |
| 0.032 | 0.029 | 0.032 | Glutamate (mGluR4) agonist | |||
| 0.023 | 0.02 | 0.023 | Prostaglandin H2 antagonist | |||
| 0.025 | 0.022 | 0.025 | Uridine phosphorylase inhibitor | |||
| 0.04 | 0.039 | 0.04 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.19 | 0.188 | 0.19 | Vasodilator, peripheral | |||
| 0.019 | 0.018 | 0.019 | Retinoid X beta receptor antagonist | |||
| 0.026 | 0.025 | 0.047 | AMPA 2 receptor antagonist | 0.047 0.012 CID_129847590 | CID_129847590 | |
| 0.124 | 0.123 | 0.124 | Dual specificity phosphatase 3 inhibitor | |||
| 0.212 | 0.216 | 0.454 | Antibacterial | 0.454 0.055 CID_129847590 | CID_129847590 | |
| 0.055 | 0.06 | 0.063 | Caspase 9 inhibitor | 0.063 0.042 CID_129847590 | CID_129847590 | |
| 0.032 | 0.037 | 0.042 | Glutamate (mGluR8) antagonist | 0.042 0.015 CID_129847590 | CID_129847590 | |
| 0.11 | 0.116 | 0.13 | Cell wall synthesis inhibitor | 0.13 0.086 CID_129847590 | CID_129847590 | |
| 0.036 | 0.044 | 0.04 | VCAM-1 antagonist | 0.04 0.026 CID_129847590 | CID_129847590 | |
| 0.036 | 0.044 | 0.04 | VCAM antagonist | 0.04 0.027 CID_129847590 | CID_129847590 | |
| 0.092 | 0.106 | 0.121 | Caspase 3 inhibitor | 0.121 0.059 CID_129847590 | CID_129847590 | |
| 0.029 | 0.045 | 0.231 | Toll-Like receptor 2 agonist | 0.231 0.005 CID_129847590 | CID_129847590 | |
| 0.047 | 0.063 | 0.108 | Botulinum neurotoxin type A inhibitor | 0.108 0.008 CID_129847590 | CID_129847590 | |
| 0.018 | 0.035 | 0.091 | Lysine carboxypeptidase inhibitor | 0.091 0.004 CID_129847590 | CID_129847590 | |
| 0.032 | 0.049 | 0.266 | Glycine transporter 2 inhibitor | 0.266 0.004 CID_129847590 | CID_129847590 | |
| 0.192 | 0.211 | 0.471 | Histamine release inhibitor | 0.471 0.04 CID_129847590 | CID_129847590 | |
| 0.047 | 0.068 | 0.3 | Neutrophil collagenase inhibitor | 0.3 0.004 CID_129847590 | CID_129847590 | |
| 0.039 | 0.062 | 0.068 | Bombesin 2 receptor antagonist | 0.068 0.02 CID_129847590 | CID_129847590 | |
| 0.029 | 0.052 | 0.048 | Membrane dipeptidase inhibitor | 0.048 0.018 CID_129847590 | CID_129847590 | |
| 0.008 | 0.036 | 0.033 | Aminopeptidase A inhibitor | 0.033 0.006 CID_129847590 | CID_129847590 | |
| 0.029 | 0.062 | 0.072 | Antimetabolite | 0.072 0.021 CID_129847590 | CID_129847590 | |
| 0.108 | 0.147 | 0.271 | Thiol protease inhibitor | 0.271 0.023 CID_129847590 | CID_129847590 | |
| 0.023 | 0.067 | 0.048 | Carboxypeptidase B inhibitor | 0.048 0.007 CID_129847590 | CID_129847590 | |
| 0.143 | 0.19 | 0.277 | Calpain inhibitor | 0.277 0.043 CID_129847590 | CID_129847590 | |
| 0.007 | 0.058 | 0.029 | VLA-4 antagonist | 0.029 0.017 CID_129847590 | CID_129847590 | |
| 0.04 | 0.093 | 0.089 | Nitric oxide donor | 0.089 0.015 CID_129847590 | CID_129847590 | |
| 0.024 | 0.078 | 0.091 | Ribonucleoside-diphosphate reductase inhibitor | 0.091 0.021 CID_129847590 | CID_129847590 | |
| 0.023 | 0.081 | 0.089 | Ribonucleotide reductase inhibitor | 0.089 0.024 CID_129847590 | CID_129847590 | |
| 0.044 | 0.103 | 0.083 | Protease 3C (Human rhinovirus) inhibitor | 0.083 0.025 CID_129847590 | CID_129847590 | |
| 0.015 | 0.078 | 0.034 | Methionyl aminopeptidase 1 inhibitor | 0.034 0.019 CID_129847590 | CID_129847590 | |
| 0.122 | 0.185 | 0.541 | Immunostimulant | 0.541 0.024 CID_129847590 | CID_129847590 | |
| 0.096 | 0.165 | 0.126 | Vanilloid 1 agonist | 0.126 0.075 CID_129847590 | CID_129847590 | |
| 0.07 | 0.14 | 0.212 | Mucolytic | 0.212 0.011 CID_129847590 | CID_129847590 | |
| 0.159 | 0.231 | 0.398 | Insulysin inhibitor | 0.398 0.022 CID_129847590 | CID_129847590 | |
| 0.004 | 0.078 | 0.015 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.015 0.009 CID_129847590 | CID_129847590 | |
| 0.008 | 0.09 | 0.039 | Arginase inhibitor | 0.039 0.023 CID_129847590 | CID_129847590 | |
| 0.018 | 0.102 | 0.047 | Factor XIIIa inhibitor | 0.047 0.018 CID_129847590 | CID_129847590 | |
| 0.046 | 0.13 | 0.222 | Metalloproteinase-2 inhibitor | 0.222 0.008 CID_129847590 | CID_129847590 | |
| 0.154 | 0.239 | 0.32 | Calpain 2 inhibitor | 0.32 0.102 CID_129847590 | CID_129847590 | |
| 0.019 | 0.107 | 0.061 | Integrin alpha5beta1 antagonist | 0.061 0.011 CID_129847590 | CID_129847590 | |
| 0.106 | 0.195 | 0.199 | Insulin sensitizer | 0.199 0.074 CID_129847590 | CID_129847590 | |
| 0.006 | 0.099 | 0.022 | Angiotensin-converting enzyme 2 inhibitor | 0.022 0.008 CID_129847590 | CID_129847590 | |
| 0.045 | 0.139 | 0.243 | Metalloproteinase-9 inhibitor | 0.243 0.006 CID_129847590 | CID_129847590 | |
| 0.004 | 0.1 | 0.14 | Neutral endopeptidase inhibitor | 0.14 0.004 CID_129847590 | CID_129847590 | |
| 0.026 | 0.125 | 0.088 | Aminopeptidase microsomal inhibitor | 0.088 0.021 CID_129847590 | CID_129847590 | |
| 0.018 | 0.116 | 0.067 | Aminopeptidase N inhibitor | 0.067 0.021 CID_129847590 | CID_129847590 | |
| 0.069 | 0.172 | 0.107 | M17 leucyl aminopeptidase inhibitor | 0.107 0.092 CID_129847590 | CID_129847590 | |
| 0.035 | 0.14 | 0.224 | Angiotensin-converting enzyme inhibitor | 0.224 0.004 CID_129847590 | CID_129847590 | |
| 0.007 | 0.112 | 0.024 | Aminopeptidase P inhibitor | 0.024 0.015 CID_129847590 | CID_129847590 | |
| 0.012 | 0.119 | 0.047 | Integrin antagonist | 0.047 0.028 CID_129847590 | CID_129847590 | |
| 0.089 | 0.199 | 0.331 | Growth hormone agonist | 0.331 0.027 CID_129847590 | CID_129847590 | |
| 0.017 | 0.134 | 0.051 | Erythropoietin receptor agonist | 0.051 0.021 CID_129847590 | CID_129847590 | |
| 0.075 | 0.195 | 0.379 | Angiogenesis stimulant | 0.379 0.025 CID_129847590 | CID_129847590 | |
| 0.049 | 0.17 | 0.194 | Expectorant | 0.194 0.022 CID_129847590 | CID_129847590 | |
| 0.016 | 0.139 | 0.125 | Matrix metalloproteinase 1 inhibitor | 0.125 0.009 CID_129847590 | CID_129847590 | |
| 0.066 | 0.198 | 0.173 | Toll-Like receptor 2 antagonist | 0.173 0.038 CID_129847590 | CID_129847590 | |
| 0.008 | 0.152 | 0.047 | Complement C3a chemotactic receptor antagonist | 0.047 0.028 CID_129847590 | CID_129847590 | |
| 0.022 | 0.166 | 0.153 | Peroxisome proliferator-activated receptor gamma agonist | 0.153 0.012 CID_129847590 | CID_129847590 | |
| 0.024 | 0.172 | 0.192 | Matrix metalloproteinase inhibitor | 0.192 0.009 CID_129847590 | CID_129847590 | |
| 0.132 | 0.28 | 0.323 | Antithrombotic | 0.323 0.075 CID_129847590 | CID_129847590 | |
| 0.035 | 0.185 | 0.074 | Adenine nucleotide translocase inhibitor | 0.074 0.012 CID_129847590 | CID_129847590 | |
| 0.067 | 0.219 | 0.135 | Protein-tyrosine phosphatase inhibitor | 0.135 0.095 CID_129847590 | CID_129847590 | |
| 0.041 | 0.194 | 0.136 | Protease inhibitor | 0.136 0.037 CID_129847590 | CID_129847590 | |
| 0.014 | 0.168 | 0.079 | Endothelin-converting enzyme inhibitor | 0.079 0.018 CID_129847590 | CID_129847590 | |
| 0.064 | 0.223 | 0.117 | Folate antagonist | 0.117 0.042 CID_129847590 | CID_129847590 | |
| 0.016 | 0.191 | 0.04 | Cholecystokinin B agonist | 0.04 0.023 CID_129847590 | CID_129847590 | |
| 0.053 | 0.229 | 0.374 | Thrombolytic | 0.374 0.014 CID_129847590 | CID_129847590 | |
| 0.05 | 0.227 | 0.111 | Transcription factor NF kappa B stimulant | 0.111 0.03 CID_129847590 | CID_129847590 | |
| 0.005 | 0.183 | 0.048 | GP IIb/IIIa receptor antagonist | 0.048 0.034 CID_129847590 | CID_129847590 | |
| 0.011 | 0.199 | 0.039 | Carbonic anhydrase I stimulant | 0.039 0.024 CID_129847590 | CID_129847590 | |
| 0.019 | 0.206 | 0.042 | Neurotensin receptor antagonist | 0.042 0.035 CID_129847590 | CID_129847590 | |
| 0.047 | 0.238 | 0.125 | Multidrug resistance-associated protein 1 inhibitor | 0.125 0.043 CID_129847590 | CID_129847590 | |
| 0.012 | 0.204 | 0.045 | Metalloproteinase-3 inhibitor | 0.045 0.04 CID_129847590 | CID_129847590 | |
| 0.038 | 0.235 | 0.081 | Chymotrypsin inhibitor | 0.081 0.053 CID_129847590 | CID_129847590 | |
| 0.031 | 0.229 | 0.056 | Cathepsin E inhibitor | 0.056 0.047 CID_129847590 | CID_129847590 | |
| 0.013 | 0.213 | 0.062 | Cathepsin L inhibitor | 0.062 0.037 CID_129847590 | CID_129847590 | |
| 0.027 | 0.232 | 0.054 | Vanilloid 2 antagonist | 0.054 0.033 CID_129847590 | CID_129847590 | |
| 0.017 | 0.224 | 0.065 | Matrix metalloproteinase (membrane-type) inhibitor | 0.065 0.028 CID_129847590 | CID_129847590 | |
| 0.011 | 0.229 | 0.059 | Macrophage elastase inhibitor | 0.059 0.019 CID_129847590 | CID_129847590 | |
| 0.017 | 0.245 | 0.051 | Bombesin antagonist | 0.051 0.029 CID_129847590 | CID_129847590 | |
| 0.043 | 0.273 | 0.102 | Proteasome inhibitor | 0.102 0.084 CID_129847590 | CID_129847590 | |
| 0.067 | 0.313 | 0.198 | Free radical scavenger | 0.198 0.099 CID_129847590 | CID_129847590 | |
| 0.036 | 0.283 | 0.275 | Chelator | 0.275 0.013 CID_129847590 | CID_129847590 | |
| 0.026 | 0.273 | 0.158 | Inducible nitric-oxide synthase inhibitor | 0.158 0.014 CID_129847590 | CID_129847590 | |
| 0.005 | 0.26 | 0.099 | Leukotriene A4 hydrolase inhibitor | 0.099 0.006 CID_129847590 | CID_129847590 | |
| 0.023 | 0.282 | 0.052 | Carbonic anhydrase II stimulant | 0.052 0.036 CID_129847590 | CID_129847590 | |
| 0.016 | 0.28 | 0.052 | Neuropeptide agonist | 0.052 0.041 CID_129847590 | CID_129847590 | |
| 0.08 | 0.354 | 0.426 | Hypoglycemic | 0.426 0.024 CID_129847590 | CID_129847590 | |
| 0.029 | 0.312 | 0.187 | Nitric-oxide synthase inhibitor | 0.187 0.012 CID_129847590 | CID_129847590 | |
| 0.006 | 0.293 | 0.028 | Bradykinin B2 receptor agonist | 0.028 0.021 CID_129847590 | CID_129847590 | |
| 0.015 | 0.31 | 0.041 | Neurokinin 2 agonist | 0.041 0.029 CID_129847590 | CID_129847590 | |
| 0.006 | 0.302 | 0.044 | AMPA receptor agonist | 0.044 0.013 CID_129847590 | CID_129847590 | |
| 0.019 | 0.315 | 0.078 | Sirtuin 1 inhibitor | 0.078 0.037 CID_129847590 | CID_129847590 | |
| 0.011 | 0.32 | 0.073 | Selectin antagonist | 0.073 0.04 CID_129847590 | CID_129847590 | |
| 0.012 | 0.327 | 0.089 | Glucagon-like peptide 1 agonist | 0.089 0.028 CID_129847590 | CID_129847590 | |
| 0.045 | 0.364 | 0.196 | Hematopoietic | 0.196 0.01 CID_129847590 | CID_129847590 | |
| 0.019 | 0.339 | 0.066 | Cathepsin B inhibitor | 0.066 0.031 CID_129847590 | CID_129847590 | |
| 0.056 | 0.394 | 0.196 | Antioxidant | 0.196 0.117 CID_129847590 | CID_129847590 | |
| 0.034 | 0.389 | 0.103 | Nav1.4 sodium channel blocker | 0.103 0.071 CID_129847590 | CID_129847590 | |
| 0.053 | 0.411 | 0.305 | Hepatoprotectant | 0.305 0.028 CID_129847590 | CID_129847590 | |
| 0.027 | 0.392 | 0.099 | Factor XII inhibitor | 0.099 0.038 CID_129847590 | CID_129847590 | |
| 0.046 | 0.423 | 0.217 | Vasodilator | 0.217 0.092 CID_129847590 | CID_129847590 | |
| 0.088 | 0.469 | 0.311 | Apoptosis antagonist | 0.311 0.078 CID_129847590 | CID_129847590 | |
| 0.039 | 0.457 | 0.195 | Histone deacetylase SIRT1 inhibitor | 0.195 0.032 CID_129847590 | CID_129847590 | |
| 0.032 | 0.473 | 0.331 | Platelet antagonist | 0.331 0.043 CID_129847590 | CID_129847590 | |
| 0.004 | 0.462 | 0.027 | Protocollagen prolyl hydroxylase inhibitor | 0.027 0.02 CID_129847590 | CID_129847590 | |
| 0.077 | 0.542 | 0.501 | Cyclophilin D inhibitor | 0.501 0.05 CID_129847590 | CID_129847590 | |
| 0.02 | 0.486 | 0.296 | Histone deacetylase class III inhibitor | 0.296 0.005 CID_129847590 | CID_129847590 | |
| 0.018 | 0.516 | 0.077 | Somatostatin 1 agonist | 0.077 0.055 CID_129847590 | CID_129847590 | |
| 0.013 | 0.584 | 0.09 | Aminoacyl-tRNA synthetase inhibitor | 0.09 0.058 CID_129847590 | CID_129847590 | |
| 0.007 | 0.62 | 0.072 | Analgesic, opioid | 0.072 0.059 CID_129847590 | CID_129847590 | |
| 0.007 | 0.622 | 0.039 | Growth hormone release inhibitor | 0.039 0.033 CID_129847590 | CID_129847590 | |
| 0.017 | 0.65 | 0.422 | Interleukin antagonist | 0.422 0.028 CID_129847590 | CID_129847590 | |
| 0.003 | 0.733 | 0.04 | Renin inhibitor | 0.04 0.023 CID_129847590 | CID_129847590 | |
| 0.011 | 0.745 | 0.059 | Bombesin 1 receptor agonist | 0.059 0.043 CID_129847590 | CID_129847590 | |
| 0.008 | 0.794 | 0.043 | Cathepsin F inhibitor | 0.043 0.025 CID_129847590 | CID_129847590 | |
| 0.005 | 0.842 | 0.215 | Hypolipemic | 0.215 0.085 CID_129847590 | CID_129847590 | |
| 0.005 | 0.87 | 0.218 | Anticoagulant | 0.218 0.047 CID_129847590 | CID_129847590 | |
| 0.005 | 0.979 | 0.195 | Immunomodulator | 0.195 0.171 CID_129847590 | CID_129847590 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |